论文信息 - Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer - 字舞流文

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

L. Crinò | M. Tonato | M. Colozza | S. Gori | E. Franceschi | A. Sidoni | V. Angelis | C. Basurto | A. Rulli | A. Mosconi | R. Cherubini | C. Bisacci